These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 22684028)

  • 1. Pharmacophore-based virtual screening and density functional theory approach to identifying novel butyrylcholinesterase inhibitors.
    Sakkiah S; Lee KW
    Acta Pharmacol Sin; 2012 Jul; 33(7):964-78. PubMed ID: 22684028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel butyrylcholinesterase inhibitors through pharmacophore modeling, virtual screening and DFT-based approaches along-with design of bioisosterism-based analogues.
    Gogoi D; Chaliha AK; Sarma D; Kakoti BB; Buragohain AK
    Biomed Pharmacother; 2017 Jan; 85():646-657. PubMed ID: 27903422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacophore-based drug design for the identification of novel butyrylcholinesterase inhibitors against Alzheimer's disease.
    Jiang Y; Gao H
    Phytomedicine; 2019 Feb; 54():278-290. PubMed ID: 30668379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of important chemical features of 11β-hydroxysteroid dehydrogenase type1 inhibitors: application of ligand based virtual screening and density functional theory.
    Sakkiah S; Meganathan C; Sohn YS; Namadevan S; Lee KW
    Int J Mol Sci; 2012; 13(4):5138-5162. PubMed ID: 22606035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacophore modeling, virtual screening, molecular docking studies and density functional theory approaches to identify novel ketohexokinase (KHK) inhibitors.
    Kavitha R; Karunagaran S; Chandrabose SS; Lee KW; Meganathan C
    Biosystems; 2015 Dec; 138():39-52. PubMed ID: 26521124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents.
    Gao H; Jiang Y; Zhan J; Sun Y
    Bioorg Chem; 2021 Sep; 114():105149. PubMed ID: 34252860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacophore modeling, molecular docking, and molecular dynamics simulation approaches for identifying new lead compounds for inhibiting aldose reductase 2.
    Sakkiah S; Thangapandian S; Lee KW
    J Mol Model; 2012 Jul; 18(7):3267-82. PubMed ID: 22249747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Silico Study Probes Potential Inhibitors of Human Dihydrofolate Reductase for Cancer Therapeutics.
    Rana RM; Rampogu S; Zeb A; Son M; Park C; Lee G; Yoon S; Baek A; Parameswaran S; Park SJ; Lee KW
    J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30754680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual binding site and selective acetylcholinesterase inhibitors derived from integrated pharmacophore models and sequential virtual screening.
    Gupta S; Mohan CG
    Biomed Res Int; 2014; 2014():291214. PubMed ID: 25050335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of new butyrylcholinesterase inhibitors via structure-based virtual screening.
    Atatreh N; Al Rawashdah S; Al Neyadi SS; Abuhamdah SM; Ghattas MA
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1373-1379. PubMed ID: 31347933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacophore-based virtual screening approach for identification of potent natural modulatory compounds of human Toll-like receptor 7.
    Gupta CL; Babu Khan M; Ampasala DR; Akhtar S; Dwivedi UN; Bajpai P
    J Biomol Struct Dyn; 2019 Nov; 37(18):4721-4736. PubMed ID: 30661449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay.
    Jang C; Yadav DK; Subedi L; Venkatesan R; Venkanna A; Afzal S; Lee E; Yoo J; Ji E; Kim SY; Kim MH
    Sci Rep; 2018 Oct; 8(1):14921. PubMed ID: 30297729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of New Selective Butyrylcholinesterase (BChE) Inhibitors with Anti-Aβ Aggregation Activity: Structure-Based Virtual Screening, Hit Optimization and Biological Evaluation.
    Jiang CS; Ge YX; Cheng ZQ; Wang YY; Tao HR; Zhu K; Zhang H
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31311169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Selective Butyrylcholinesterase (BChE) Inhibitors through a Combination of Computational Studies and Biological Evaluations.
    Zhou Y; Lu X; Yang H; Chen Y; Wang F; Li J; Tang Z; Cheng X; Yang Y; Xu L; Xia Q
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31757047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel chemical scaffolds of the tumor marker AKR1B10 inhibitors discovered by 3D QSAR pharmacophore modeling.
    Kumar R; Son M; Bavi R; Lee Y; Park C; Arulalapperumal V; Cao GP; Kim HH; Suh JK; Kim YS; Kwon YJ; Lee KW
    Acta Pharmacol Sin; 2015 Aug; 36(8):998-1012. PubMed ID: 26051108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery, biological evaluation and molecular dynamic simulations of butyrylcholinesterase inhibitors through structure-based pharmacophore virtual screening.
    Lu T; Liu Y; Liu Y; Chen H; Han C; Feng X; Zhou H; Li Y
    Future Med Chem; 2021 May; 13(9):769-784. PubMed ID: 33759552
    [No Abstract]   [Full Text] [Related]  

  • 17. 3D QSAR pharmacophore based virtual screening and molecular docking for identification of potential HSP90 inhibitors.
    Sakkiah S; Thangapandian S; John S; Kwon YJ; Lee KW
    Eur J Med Chem; 2010 Jun; 45(6):2132-40. PubMed ID: 20206418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of the scaffold diversity for the development of highly selective butyrylcholinesterase (BChE) inhibitors: Discovery of new hits through the pharmacophore model generation, virtual screening and molecular dynamics simulation.
    Lu X; Yang H; Li Q; Chen Y; Li Q; Zhou Y; Feng F; Liu W; Guo Q; Sun H
    Bioorg Chem; 2019 Apr; 85():117-127. PubMed ID: 30605885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-based pharmacophore modeling and Bayesian approaches to identify c-Src inhibitors.
    Sakkiah S; Arullaperumal V; Hwang S; Lee KW
    J Enzyme Inhib Med Chem; 2014 Feb; 29(1):69-80. PubMed ID: 23432516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of non-hydroxamate scaffolds against HDAC6 inhibition: A pharmacophore modeling, molecular docking, and molecular dynamics simulation approach.
    Zeb A; Park C; Son M; Rampogu S; Alam SI; Park SJ; Lee KW
    J Bioinform Comput Biol; 2018 Jun; 16(3):1840015. PubMed ID: 29945500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.